Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer (NYSE:PFE) recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at ...

Pfizer reckons it will make ... that the company is " ripping off public health systems with an eye-watering mark-up." The comments came as the COVAX initiative to supply COVID-19 vaccines to ...

UC San Diego's Moores Cancer Center has received a $1 million donation from pharmaceutical giant Pfizer to support early ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

Now given Pfizer's growing pipeline of new drug launches ... other mechanisms of action to address this growing global health challenge. Pfizer has a huge pipeline of new drugs that can hit ...

and Pfizer’s ‘Get Real’ anti-counterfeit initiative from 2009. At the start of this year in this column, I reviewed a number of winners recognised in the last Healthcare Engagement Strategy ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company's strategic expansion in China.